NEW YORK (GenomeWeb) – Interpace Diagnostics announced today that it has signed a laboratory services agreement to provide its molecular thyroid tests to researchers at Einstein Medical Center of Philadelphia.

Under the terms of the deal, Einstein's endocrinologists and otolaryngologists will have access to Interpace's ThyGenX oncogene panel and ThyraMir microRNA gene expression classifier, which are used to diagnose thyroid nodules with indeterminate cytology. 

Additional terms were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.